Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GR1501 Injection in Active Axial Spondyloarthritis
CTR20201602Phase 2Completed
- Sponsor
- Zhixiang Jintai
- Start
- Aug 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of xeligekimab in axial spondyloarthritis (axSpA), sponsored by Zhixiang Jintai. Started Aug 2020; status: completed.
02
Drugs
xeligekimab
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on CTR20201602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201602.